Consumer Information on Why the U.S. is Eliminating the Use of Ozone-Depleting Substances

Included here are brochures, magazine articles, and talk papers about why the U.S. is eliminating the use of ozone-depleting substances and how this elimination will affect Metered-Dose Inhalers (MDIs).

• Frequently Asked Questions
  Have you heard about FDA proposals regarding MDIs? Do you want to know why MDIs are changing? Do you want to know what other types of medication are available? Get the facts here.
  
  
• FDA Consumer article on the phase-out of CFC-MDIs
  This article in the May-June 1997 FDA Consumer explains the relationship between CFCs, MDIs, and the environment.
  
  
• FDA Talk Paper answering common questions about CFC-MDIs
  FDA answers questions about the transition away from the use of CFC-MDIs.
  


• International Pharmaceutical Aerosol Consortium (IPAC)*
  IPAC discusses in detail the MDI and upcoming changes.
   
  
• Your-Metered Dose Inhaler Will Be Changing... Here Are The Facts*
  This brochure for asthma patients explains the reasons behind the change and how it might affect patients. It is published by the National Asthma Education and Prevention Program and was created by a partnership of numerous organizations, including FDA.
  


• "Your Metered-Dose Inhaler is Changing to Help Improve the Environment" (9/22/2003)
  Public Service Announcements
  • One-page version:
    • graphic image-PDF
    • text-HTML
  • Two-page version:
    • graphic image-PDF
    • text-HTML

FDA/Center for Drug Evaluation and Research
Last Updated: September 22, 2003
Originator: OCD/RPS
HTML by  LC;CSA;MAU